Ekta Bagri Profile - Zacks Equity Research Blogger
4 Followers
Ekta Bagri Zacks Equity Research
Financial Blogger
Success Rate
20 out of 52 ratings made a profit
Average Return
-1.50%
Average return per rating
Time Frame
Compare to
Copying Ekta Bagri's trades since 2018 and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of -1.5% per rating.
Stock Rating Distribution
64.71% Bullish
22.06% Neutral
13.24% Bearish
Distribution of Ekta Bagri's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
The most profitable rating made by Ekta Bagri
Ekta Bagri's Stock Coverage
Vertex Pharmaceuticals
Aug 23, 2018
Bullish
1Ratings
+2.30%
Biogen
Dec 11, 2018
Bullish
1Ratings
-8.60%
Novartis
Jul 29, 2021
Bullish
1Ratings
-4.40%
Regeneron
Jan 05, 2024
Bullish
3Ratings
-15.37%
Sarepta Therapeutics
Jan 05, 2024
Bullish
1Ratings
+29.70%
BeOne Medicines
Jan 05, 2024
Bullish
1Ratings
+9.30%
Vanda
Dec 29, 2025
Bullish
1Ratings
-29.30%
Grifols SA
Jul 08, 2026
Neutral
1Ratings
―
0.00%
Takeda Pharmaceutical Company
Jul 08, 2026
Neutral
1Ratings
―
0.00%
Exelixis
Jul 13, 2026
Bullish
1Ratings
+0.10%
List of latest recommendations made by Ekta Bagri. Click to expand and see Ekta Bagri's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.